Park, Cheol Ho
Hong, Soon Jun
Kim, Sung Gyun
Shin, Seok Joon
Kim, Dong Ki
Lee, Jung Pyo
Han, Sang Youb
Lee, Sangho
Won, Jong Chul
Kang, Young Sun
Park, Jongha
Han, Byoung-Geun
Na, Ki-Ryang
Hur, Kyu Yeon
Kim, Yong-Jin
Park, Sungha
Yoo, Tae-Hyun
Funding for this research was provided by:
Boryung Pharmaceutical
Article History
Received: 24 January 2024
Accepted: 16 June 2024
First Online: 1 August 2024
Declarations
:
: All participants provided written informed consent based on the documents approved by each participating centers’ Institutional Review Board (Severance Hospital: 4–2015-0848).
: Not applicable.
: S.P. received lecture fees from Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo and Daewon. S.P. also received research grant from Daiichi Sankyo. Y.J.K. received consultation fee from Celltrion and received lecture fees from Yuhan, Daewoong, Daiichi Sankyo, Bayer, Takeda, and GC pharma. S.J.H. received lecture fees and research sponsoring from Hanmi, InnoN, Samjin and Boryung. S.G.K. received lecture fees and research sponsoring from Yuhan, JW Pharma, AstraZeneca, GSK, Fibrogen, Akebia, Omeros, Chinook, MorphoSys, Otsuka and Boryung. J.C.W. received lecture fees and research sponsoring from Chong Kun Dang, Daewoong, Eli Lilly, Yuhan and Boryung.